Načítá se...
Axitinib in sequential therapy in metastatic renal cell carcinoma
Efficacy of new molecularly targeted drugs in the treatment of renal cell carcinoma (RCC), confirmed in clinical studies in relation to survival and prolongation of time to progression, has became a big chance for patients with metastatic renal cell cancer. Axitinib is a potent and selective recepto...
Uloženo v:
| Vydáno v: | Contemp Oncol (Pozn) |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5371698/ https://ncbi.nlm.nih.gov/pubmed/28373826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2015.51823 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|